NOBELREPLACE: payments to doctors
Payments that named NOBELREPLACE as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.1M
- Providers
- 4,324
- Transactions
- 9,289
- Average per transaction
- $221
The per-transaction average — $221 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,324 providers the average total is $474, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Nobel Biocare USA | $2,047,438 | 99.8% |
| Kerr Corporation | $3,658 | 0.2% |
| Ormco Corporation | $66 | 0.0% |
| Envista Holdings Corporation | $15 | 0.0% |